CapitalBio Corporation Certified to Provide NimbleGen Array Services in China
News Feb 15, 2010
Roche NimbleGen has announced that Beijing-based genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.
CapitalBio has been certified to process customer samples for NimbleGen Gene Expression, Comparative Genomic Hybridization/Copy Number Variation (CGH/CNV), and DNA Methylation services in their lab in Beijing, China and is the first NimbleGen CSP in Asia to implement the MS 200 Microarray Scanner into their array workflow for high-resolution scanning. CapitalBio brings six years experience of genetic research services to the Chinese scientific community, which was instrumental in their certification as a service provider.
“The launch of the Roche NimbleGen CSP Program at CapitalBio represents a major step forward in our efforts to bring advanced DNA analysis to China” said Junquan XU, Vice President of Operations at CapitalBio.
“We will now be able to expand our service to customers through access of the complete NimbleGen Single-Color (Gene Expression) or Dual-Color (CGH/CNV & DNA Methylation) workflow. We are pleased to have passed the rigorous certification procedures and experimental standards to become part of the Roche NimbleGen CSP Program,” XU said.
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.